Biosprendimų laboratorija, UAB - financials and debts

Company age: 7 y. 8 mo.

Update

Biosprendimų laboratorija - Company finances

EUR
2019
From: 2019-01-25
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 20,385 66,448 199,801 128,104 162,489 195,431 95,447
Profit before tax -2,557 -5,835 54,441 43,674 46,300 41,333 -20,748
Net profit -2,557 -5,835 52,136 43,674 46,300 41,333 -20,748
Equity 43 -5,792 46,115 90,911 137,211 180,498 185,793
Liabilities 65,839 101,985 135,727 168,735 265,824 242,134 128,681
Non-current assets 1,202 802 401 1,511 993 23,601 20,626
Current assets 64,680 95,391 180,968 258,135 402,042 398,495 292,398
Total assets 65,882 96,193 181,369 259,646 403,035 422,096 313,024
Taxes paid
STI taxes - - - - 43,655 47,304 9,288
Social insurance contributions - - - - - - 646
Financial indicators
Revenue change y/y - +226.0% +200.7% -35.9% +26.8% +20.3% -51.2%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -3.9% -6.1% 28.7% 16.8% 11.5% 9.8% -6.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -5946.5% - 113.1% 48.0% 33.7% 22.9% -11.2%
Profit margin Net profit margin. Shows the overall profitability of the company. -12.5% -8.8% 26.1% 34.1% 28.5% 21.1% -21.7%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -12.5% -8.8% 27.2% 34.1% 28.5% 21.1% -21.7%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1531.1 - 2.9 1.9 1.9 1.3 0.7
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 20,385 66,448 108,984 61,491 54,163 53,299 24,899

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Biosprendimų laboratorija - Social security debts

From To Debt, €
2024-07-24 2024-07-29 4.95
2024-07-16 2024-07-23 4.50
2024-05-21 2024-07-14 4.50
2024-05-17 2024-05-20 12.43
2024-05-16 2024-05-16 12.12
2024-04-19 2024-05-14 12.12
2023-01-24 2023-01-26 377.99
2023-01-23 2023-01-23 367.83
2023-01-20 2023-01-22 377.99
2023-01-17 2023-01-19 367.83
2022-06-16 2022-08-22 0.03
2022-05-17 2022-06-14 0.03
2022-04-28 2022-05-15 0.03
2022-03-16 2022-03-21 14.27
2022-02-17 2022-03-14 0.42
2022-01-18 2022-02-14 0.42
2021-12-16 2022-01-13 0.42

Biosprendimų laboratorija - VMI tax arrears

From To Overdue, €
2026-02-03 2026-02-03 4538.37
2026-01-31 2026-02-02 4534.98
2026-01-30 2026-01-30 4590.71
2026-01-29 2026-01-29 4381.89
2026-01-13 2026-01-16 29.44

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Biosprendimu laboratorija, UAB (code 304997426) is a Private Limited Liability Company engaged in the wholesale of agrochemical products and fertilisers. In 2025, the company generated revenue of €95.4K, down 51.2% year on year and 41.3% compared with 2023. Net result turned to a loss of €20.7K, after profits of €41.3K in 2024 and €46.3K in 2023. The profit margin therefore weakened from 21.1% in 2024 to -21.7% in 2025, reflecting the decline in turnover and the shift into loss-making operations. The balance sheet remained solid, with total assets of €313.0K, equity of €185.8K and liabilities of €128.7K at the end of 2025. Equity represented 59.4% of assets, while debt-to-equity stood at 0.69. Asset turnover was 0.30x, and ROE and ROA were -11.2% and -6.6%, respectively. Revenue per employee was €31.8K, while profit per employee was -€6.9K.